Results 221 to 230 of about 484,364 (380)

Would You Take an Open-Label Placebo Pill or Give One to Your Child? Findings from a Cross-Sectional Survey

open access: yesPsychology Research and Behavior Management
Anne Schienle, Arved Seibel Department of Clinical Psychology, University of Graz, Graz, AustriaCorrespondence: Anne Schienle, Email anne.schienle@uni-graz.atBackground: Open-label placebos (OLPs), honestly prescribed regarding their inert nature, have ...
Schienle A, Seibel A
doaj  

Teaching neurons to respond to placebos

open access: yesJournal of Physiology, 2016
F. Benedetti   +7 more
semanticscholar   +1 more source

Expert insight into the education of healthcare professionals on medication adherence

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Medication non‐adherence is a global health problem affecting patients with numerous medical conditions. Training healthcare professionals (HCPs) on managing the challenging issue of medication non‐adherence requires an evidence‐based approach.
Fatima Rezae   +3 more
wiley   +1 more source

Problematic placebos in physical therapy trials.

open access: yesJournal of Evaluation In Clinical Practice, 2016
M. Maddocks   +3 more
semanticscholar   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani   +4 more
wiley   +1 more source

Putting placebos to the test. [PDF]

open access: yesPLoS Biology, 2017
Liza Gross
doaj   +1 more source

Home - About - Disclaimer - Privacy